Volume 18, Issue 36 2106569
Review

Functional Extracellular Vesicles for Regenerative Medicine

Han Young Kim

Han Young Kim

Department of Biomedical-Chemical Engineering, The Catholic University of Korea, Bucheon, 14662 Republic of Korea

Search for more papers by this author
Seunglee Kwon

Seunglee Kwon

School of Chemical Engineering, Sungkyunkwan University, Suwon, 16419 Republic of Korea

Search for more papers by this author
Wooram Um

Wooram Um

School of Chemical Engineering, Sungkyunkwan University, Suwon, 16419 Republic of Korea

Search for more papers by this author
Sol Shin

Sol Shin

Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, 06351 Republic of Korea

Search for more papers by this author
Chan Ho Kim

Chan Ho Kim

School of Chemical Engineering, Sungkyunkwan University, Suwon, 16419 Republic of Korea

Search for more papers by this author
Jae Hyung Park

Corresponding Author

Jae Hyung Park

School of Chemical Engineering, Sungkyunkwan University, Suwon, 16419 Republic of Korea

Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, 06351 Republic of Korea

Biomedical Institute for Convergence at SKKU, Sungkyunkwan University, Suwon, 16419 Republic of Korea

E-mail: [email protected]; [email protected]

Search for more papers by this author
Byung-Soo Kim

Corresponding Author

Byung-Soo Kim

School of Chemical and Biological Engineering, Interdisciplinary Program of Bioengineering, Institute of Chemical Processes, Institute of Engineering Research, BioMAX, Seoul National University, Seoul, 08826 Republic of Korea

E-mail: [email protected]; [email protected]

Search for more papers by this author
First published: 23 March 2022
Citations: 12

Abstract

The unique biological characteristics and promising clinical potential of extracellular vesicles (EVs) have galvanized EV applications for regenerative medicine. Recognized as important mediators of intercellular communication, naturally secreted EVs have the potential, as innate biotherapeutics, to promote tissue regeneration. Although EVs have emerged as novel therapeutic agents, challenges related to the clinical transition have led to further functionalization. In recent years, various engineering approaches such as preconditioning, drug loading, and surface modification have been developed to potentiate the therapeutic outcomes of EVs. Also, limitations of natural EVs have been addressed by the development of artificial EVs that offer advantages in terms of production yield and isolation methodologies. In this review, an updated overview of current techniques is provided for the functionalization of natural EVs and recent advances in artificial EVs, particularly in the scope of regenerative medicine.

Conflict of Interest

The authors declare no conflict of interest.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.